Article(id=1330225028316115127, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225010435796998, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2022.02.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1635955200000, receivedDateStr=2021-11-04, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795079961136, onlineDateStr=2026-11-19, pubDate=1644422400000, pubDateStr=2022-02-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795079961136, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795079961136, creator=13701087609, updateTime=1795079961136, updator=13701087609, issue=Issue{id=1330225010435796998, tenantId=1146029695717560320, journalId=1319690329412173987, year='2022', volume='43', issue='2', pageStart='109', pageEnd='209', issueExtLink='null', onlineDate='null', pubDate='1644422400000', pubDateStr='2022-02-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795079956873, creator='13701087609', updateTime=1795084674007, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330244795886318219, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225010435796998, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330244795886318220, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225010435796998, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=115, endPage=123, ext={EN=ArticleExt(id=1330225028496470200, articleId=1330225028316115127, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=International experience of gene therapy drug payment mode and its enlightenment to China, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Gene therapy, as a new type of treatment, has been applied to rare disease and other difficult medical problems, bringing hopes to patients with rare disease. However, three major challenges including difficulty in evidence generating or data collection, value evaluation (including pricing and budget impact analysis) and difficulties in payment and reimbursement. Therefore, formulating a reasonable payment was essential to protect the health of patients and improve the accessibility of gene therapy. Taking gene therapy drugs for rare disease as an example, this article summarized the current payment models and some practices in developed countries, in order to discuss how to pay for expensive gene therapy drugs within the limited budget constraints.

, authors=Ni YUAN1, Guangsheng LIANG2, Hanyu CHANG3, Meiqi WANG1, Xiaoyan GUAN1, Jun HU4, authorsList=Ni YUAN, Guangsheng LIANG, Hanyu CHANG, Meiqi WANG, Xiaoyan GUAN, Jun HU, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330225028743934137, articleId=1330225028316115127, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=基因治疗药物支付方式的国际经验及对我国的启示, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

基因治疗作为一种新型治疗手段,目前已被用于罕见病等多种疑难医学问题,为罕见病患者带来了新的希望。但目前基因治疗面临3大难题,包括生成/数据采集难、价值评估(包括定价和预算影响分析)难及支付报销难。因此,制定合理的付费模式对于保障患者生命健康权、提高基因治疗的患者可及性至关重要。该文以用于罕见病治疗的基因治疗药物为例,针对其支付报销难题,梳理了当前主流的几种付费模式和部分发达国家的具体实践,以探讨在不突破预算限制的条件下如何为昂贵的基因治疗药物买单。

, authors=袁妮1, 梁广盛2, 常翰玉3, 王美琪1, 关晓岩1, 胡骏4, authorsList=袁妮, 梁广盛, 常翰玉, 王美琪, 关晓岩, 胡骏, authorCompany=null, correspAuthors=null, authorNote=

袁妮,副教授,研究方向:医疗保障政策、药物经济学、药物政策。

, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=daNm8Qqo12YJFjEEiHDyqg==, magXml=cCWCxX36ZfHDK3Qan1cpfg==, pdfUrl=null, pdf=7B4seDdABbf+O3s44d63rg==, pdfFileSize=1710676, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=hnGgh8PpxhEtozCnXqtFwg==, mapNumber=null, fund=null)}, authors=[Author(id=1330225030773977289, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225030849474763, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225030773977289, language=EN, stringName=Ni YUAN, firstName=Ni, middleName=null, lastName=YUAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of Public Health, Dalian Medical University, Dalian 116044, Liaoning Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225030908195020, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225030773977289, language=CN, stringName=袁妮, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.大连医科大学公共卫生学院,辽宁 大连 116044, bio={"content":"

袁妮,副教授,研究方向:医疗保障政策、药物经济学、药物政策。

"}, bioImg=null, bioContent=

袁妮,副教授,研究方向:医疗保障政策、药物经济学、药物政策。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225028932677820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, xref=1., ext=[AuthorCompanyExt(id=1330225028941066429, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225028932677820, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Public Health, Dalian Medical University, Dalian 116044, Liaoning Province, China), AuthorCompanyExt(id=1330225028949455038, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225028932677820, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.大连医科大学公共卫生学院,辽宁 大连 116044)])]), Author(id=1330225030979498190, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225031046607056, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225030979498190, language=EN, stringName=Guangsheng LIANG, firstName=Guangsheng, middleName=null, lastName=LIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.China Welfare Association International Peace Maternal and Child Health Hospital, Shanghai 200030, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225031122104529, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225030979498190, language=CN, stringName=梁广盛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.中国福利会国际和平妇幼保健院,上海 200030, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225030513930431, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, xref=2., ext=[AuthorCompanyExt(id=1330225030522319040, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225030513930431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.China Welfare Association International Peace Maternal and Child Health Hospital, Shanghai 200030, China), AuthorCompanyExt(id=1330225030526513345, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225030513930431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国福利会国际和平妇幼保健院,上海 200030)])]), Author(id=1330225031193407699, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225031273099477, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225031193407699, language=EN, stringName=Hanyu CHANG, firstName=Hanyu, middleName=null, lastName=CHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.Department of Medical Insurance Administration, The First Hospital of Lanzhou University, Lanzhou 730013, Gansu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225031336014038, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225031193407699, language=CN, stringName=常翰玉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.兰州大学第一医院医保管理处,甘肃 兰州 730013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225030593622210, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, xref=3., ext=[AuthorCompanyExt(id=1330225030602010819, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225030593622210, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Medical Insurance Administration, The First Hospital of Lanzhou University, Lanzhou 730013, Gansu Province, China), AuthorCompanyExt(id=1330225030610399428, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225030593622210, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.兰州大学第一医院医保管理处,甘肃 兰州 730013)])]), Author(id=1330225031415705816, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225031491203290, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225031415705816, language=EN, stringName=Meiqi WANG, firstName=Meiqi, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of Public Health, Dalian Medical University, Dalian 116044, Liaoning Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225031545729243, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225031415705816, language=CN, stringName=王美琪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.大连医科大学公共卫生学院,辽宁 大连 116044, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225028932677820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, xref=1., ext=[AuthorCompanyExt(id=1330225028941066429, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225028932677820, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Public Health, Dalian Medical University, Dalian 116044, Liaoning Province, China), AuthorCompanyExt(id=1330225028949455038, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225028932677820, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.大连医科大学公共卫生学院,辽宁 大连 116044)])]), Author(id=1330225031608643806, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225031671558368, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225031608643806, language=EN, stringName=Xiaoyan GUAN, firstName=Xiaoyan, middleName=null, lastName=GUAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of Public Health, Dalian Medical University, Dalian 116044, Liaoning Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225031730278625, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225031608643806, language=CN, stringName=关晓岩, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.大连医科大学公共卫生学院,辽宁 大连 116044, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225028932677820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, xref=1., ext=[AuthorCompanyExt(id=1330225028941066429, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225028932677820, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Public Health, Dalian Medical University, Dalian 116044, Liaoning Province, China), AuthorCompanyExt(id=1330225028949455038, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225028932677820, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.大连医科大学公共卫生学院,辽宁 大连 116044)])]), Author(id=1330225031784804579, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225031856107749, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225031784804579, language=EN, stringName=Jun HU, firstName=Jun, middleName=null, lastName=HU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=4, address=4.Shanghai Adverse Reaction Monitoring Center for Drugs and Medical Devices, Shanghai 200040, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225031914828006, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225031784804579, language=CN, stringName=胡骏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=4, address=4.上海市药品和医疗器械不良反应监测中心,上海 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225030694285509, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, xref=4., ext=[AuthorCompanyExt(id=1330225030702674118, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225030694285509, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.Shanghai Adverse Reaction Monitoring Center for Drugs and Medical Devices, Shanghai 200040, China), AuthorCompanyExt(id=1330225030706868423, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225030694285509, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.上海市药品和医疗器械不良反应监测中心,上海 200040)])])], keywords=[Keyword(id=1330225031990325479, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, language=EN, orderNo=1, keyword=rare disease), Keyword(id=1330225032057434344, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, language=EN, orderNo=2, keyword=gene therapy), Keyword(id=1330225032128737513, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, language=EN, orderNo=3, keyword=payment and reimbursement), Keyword(id=1330225032183263466, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, language=CN, orderNo=1, keyword=罕见病), Keyword(id=1330225032237789419, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, language=CN, orderNo=2, keyword=基因治疗药物), Keyword(id=1330225032296509676, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, language=CN, orderNo=3, keyword=支付及报销)], refs=[Reference(id=1330225032472670446, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=迟培娟, 陈芳, Liu C, 等. 基因治疗及细胞治疗发展态势分析[J]. 中国生物工程杂志, 2019, 39(5): 43-52., articleTitle=null, refAbstract=null), Reference(id=1330225032531390703, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=张岩松, 陈丽娇, 张婷, 等. 基因治疗的研究进展[J]. 中国细胞生物学学报, 2020, 42(10): 1858-1869., articleTitle=null, refAbstract=null), Reference(id=1330225032594305264, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang D, Wang K, Cai Y. An overview of development in gene therapeutics in China[J]. Gene Ther, 2020, 27(7-8): 338-348., articleTitle=null, refAbstract=null), Reference(id=1330225032653025521, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=HUML RA. Rare disease drug development, clinical, scientifc, patient, and caregiver perspectives[M]. Switzerland: Springer Nature Switzerland AG, 2021: 251-261., articleTitle=null, refAbstract=null), Reference(id=1330225032711745778, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Quinn C, Young C, Thomas J, et al. Estimating the clinical pipeline of cell and gene therapies and their potential economic impact on the US healthcare system[J]. Value Health, 2019, 22(6): 621-626., articleTitle=null, refAbstract=null), Reference(id=1330225032783048947, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=桂怡婷, 李强, 桂永浩. 罕见病的基因治疗应用与展望[J]. 临床儿科杂志, 2020, 38(10): 794-798., articleTitle=null, refAbstract=null), Reference(id=1330225032862740724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Toby Auwerter JS. Unlocking market access for gene therapies in the United States[EB/OL]. [2021-12-25]. https://www.mckinsey.com/industries/life-sciences/our-insights/unlocking-market-access-for-gene-therapies-in-the-united-states., articleTitle=null, refAbstract=null), Reference(id=1330225032921460981, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Ledley FD. 30 Years is too long to wait for new medicines. There are ways to speed up drug development[EB/OL]. [2021-12-25]. https://www.statnews.com/2018/06/06/drug-development-speed-new-medicines/., articleTitle=null, refAbstract=null), Reference(id=1330225032984375542, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Garrison LP, Jackson T, Paul D, et al. Value-based pricing for emerging gene therapies: the economic case for a higher cost-effectiveness threshold[J]. J Manag Care Spec Pharm, 2019, 25(7): 793-799., articleTitle=null, refAbstract=null), Reference(id=1330225033043095799, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Kent A, Spink J. Will rising prices and budget constraints prevent patients from accessing novel gene therapies?[J]. Gene Ther, 2017, 24(9): 542-543., articleTitle=null, refAbstract=null), Reference(id=1330225033106010360, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Agency EM. Glybera[EB/OL]. [2021-12-25]. https://www.ema.europa.eu/en/medicines/human/EPAR/glybera., articleTitle=null, refAbstract=null), Reference(id=1330225033173119225, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA, Wang ZL, Xu T, et al. The approved gene therapy drugs worldwide: from 1998 to 2019[J]. Biotechnol Adv, 2020, 40: 107502., articleTitle=null, refAbstract=null), Reference(id=1330225033240228090, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA. Approved cellular and gene therapy products[EB/OL]. [2021-12-25]. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/approved-cellular-and-gene-therapy-products., articleTitle=null, refAbstract=null), Reference(id=1330225033298948347, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Technology P. Bluebird turns heads with high pricing of gene therapy zynteglo in Europe[EB/OL]. [2021-12-30]. https://www.pharmaceutical-technology.com/comment/zynteglo-gene-therapy-2019/., articleTitle=null, refAbstract=null), Reference(id=1330225033361862908, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=PMLIVE. NICE rejects Akcea's rare inherited disorder drug waylivra[EB/OL]. [2021-12-30]. https://www.pmlive.com/pharma_news/nice_rejects_akceas_rare_inherited_disorder_drug_waylivra_1321479., articleTitle=null, refAbstract=null), Reference(id=1330225033412194557, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Davio K. In developing payment mechanisms for gene therapies, the US has a long road ahead[EB/OL]. [2021-12-25]. https://www.ajmc.com/view/in-developing-payment-mechanisms-for-gene-therapies-the-us-has-a-long-road-ahead., articleTitle=null, refAbstract=null), Reference(id=1330225034985058558, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Dieg OB. Prices of new hepatitis C combinations lower than monotherapy in Spain in six months[EB/OL]. [2021-12-25]. https://www.apmhealtheurope.com/freestory/0/41690/prices-of-new-hepatitis-c-combinations-lower-than-monotherapy-in-spain-in-six-months., articleTitle=null, refAbstract=null), Reference(id=1330225035081527551, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Forbes. At over $2 million zolgensma is the world's most expensive therapy, yet relatively cost-effective[EB/OL]. [2021-12-25]. https://www.forbes.com/sites/joshuacohen/2019/06/05/at-over-2-million-zolgensma-is-the-worlds-most-expensive-therapy-yet-relatively-cost-effective/?sh=7bd7be7445f5., articleTitle=null, refAbstract=null), Reference(id=1330225035169607936, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Novartis. AveXis announces innovative zolgensma® gene therapy access programs for us payers and families[EB/OL]. [2021-12-25]. https://www.novartis.com/news/media-releases/avexis-announces-innovative-zolgensma-gene-therapy-access-programs-us-payers-and-families., articleTitle=null, refAbstract=null), Reference(id=1330225035245105409, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=European Commission. European system of national and regional accounts - ESA 2010[EB/OL]. [2021-12-25]. https://ec.europa.eu/eurostat/web/esa-2010/overview., articleTitle=null, refAbstract=null), Reference(id=1330225035320602882, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Brennan TA, Wilson JM. The special case of gene therapy pricing[J]. Nat Biotechnol, 2014, 32(9): 874-876., articleTitle=null, refAbstract=null), Reference(id=1330225035387711747, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Jorgensen J, Kefalas P. Reimbursement of licensed cell and gene therapies across the major European healthcare markets[J]. J Mark Access Health Policy, 2015, 3(1): 29321., articleTitle=null, refAbstract=null), Reference(id=1330225035454820612, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Tapestry Network. Building a sustainable health system for curative therapies[EB/OL]. [2021-12-25]. https://www.tapestrynetworks.com/publications/building-a-sustainable-health-system-for-curative-therapies., articleTitle=null, refAbstract=null), Reference(id=1330225035517735173, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Grace Marsden ATSD. Gene therapy: understanding the science, assessing the evidence, and paying for value[R]. Institute for Clinical and Economic Review, 2017., articleTitle=null, refAbstract=null), Reference(id=1330225035589038342, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Bubela T, Mccabe C, Archibald P, et al. Bringing regenerative medicines to the clinic: the future for regulation and reimbursement[J]. Regen Med, 2015, 10(7): 897-911., articleTitle=null, refAbstract=null), Reference(id=1330225035656147207, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Hanna E, Marre C, Toumi M. Reimbursement of advanced therapy medicinal products in Europe[J]. Value Health, 2018, 21(suppl 3): S202-S203., articleTitle=null, refAbstract=null), Reference(id=1330225035735838984, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Carvalho M, Sepodes B, Martins AP. Patient access to gene therapy medicinal products: a comprehensive review[J]. BMJ Innovations, 2021, 7: 123-134., articleTitle=null, refAbstract=null), Reference(id=1330225035798753545, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Schwander B, Banz K, Kaier K, et al. Evaluation of a possible predictor for federal joint committee decisions on early benefit assessments according to the German act on the reform of the market for medicinal products[J]. Health Policy, 2014, 117(3): 334-344., articleTitle=null, refAbstract=null), Reference(id=1330225035882639626, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Ohlenbusch S. Novartis seeking more ‘innovative pay-ment models' for CAR-T Kymriah in Germany[EB/OL]. [2021-12-25]. https://www.apmhealtheurope.com/freestory/0/63585/novartis-seeking-more–innovative-payment-models–for-car-t-kymriah-in-Germany., articleTitle=null, refAbstract=null), Reference(id=1330225035958137099, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=GKV-Spitzenverband. Erstattungsbetragsverhandlungen nach § 130b SGB V - Axicabtagen-Ciloleucel (Yescarta®). 2019 [2021-12-25]. https://www.gkv-spitzenverband.de/krankenversicherung/arzneimittel/verhandlungen_nach_amnog/ebv_130b/wirkstoff_945472.jsp., articleTitle=null, refAbstract=null), Reference(id=1330225036046217484, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Jørgensen J, Hanna E, Kefalas P. Outcomes-based reimbursement for gene therapies in practice: the experience of recently launched CAR-T cell therapies in major European countries[J]. J Market Access Health Policy, 2020, 8(1): 1715536., articleTitle=null, refAbstract=null), Reference(id=1330225036121714957, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=ABMSC. European benchmark ATMP market entry from an HTA perspective[R]. Gothenburg: Monocl Strategy & Communication AB, 2020., articleTitle=null, refAbstract=null), Reference(id=1330225036193018126, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Pharma F. GSK inks money-back guarantee on $665K Strimvelis, blazing a trail for gene-therapy pricing[EB/OL]. [2021-12-25]. https://www.fiercepharma.com/pharma/gskinks-money-back-guarantee-665k-strimvelis-blazing-a-trail-for-gene-therapy-pricing., articleTitle=null, refAbstract=null), Reference(id=1330225036260126991, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Affairs H. Medicaid best price[EB/OL]. [2021-12-25]. https://www.healthaffairs.org/do/10.1377/hpb20171008.000173/full/., articleTitle=null, refAbstract=null), Reference(id=1330225036335624464, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Sachs R, Bagley N, Lakdawalla DN. Innovative contracting for pharmaceuticals and medicaid's best-price rule. J Health Polit Policy Law, 2018, 43(1): 5-18., articleTitle=null, refAbstract=null), Reference(id=1330225036411121937, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Health Affairs Blog. Proposed stark law, anti-kickback reforms aim to facilitate value-based care[EB/OL]. [2021-12-25]. https://www.healthaffairs.org/do/10.1377/hblog20191014.13154/full/., articleTitle=null, refAbstract=null), Reference(id=1330225036495008018, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Pharmafile. Novartis' Kymriah to be covered by Japan's national insurance system[EB/OL]. [2021-12-25]. http://www.pharmafile.com/news/522188/novartis-kymriah-be-covered-japans-national-insurance-system., articleTitle=null, refAbstract=null), Reference(id=1330225036599865619, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=CJ Partners Inc. Regenerative medicine in Japan[EB/OL] [2021-12-25]. http://www.cj-partners.com/en/news/files/000026_en_01.pdf., articleTitle=null, refAbstract=null), Reference(id=1330225036675363092, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=Van Overbeeke E, Michelsen S, Toumi M, et al. Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions[J]. Drug Discov Today, 2021, 26(2): 399-415., articleTitle=null, refAbstract=null), Reference(id=1330225036746666261, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=Yu TTL, Gupta P, Ronfard V, et al. Recent progress in European advanced therapy medicinal products and beyond[J]. Front Bioeng Biotechnol, 2018, 6: 130., articleTitle=null, refAbstract=null), Reference(id=1330225036830552342, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=Pharma Intelligence. Novartis begins CAR-T payment experiments with outcomes-based contract with CMS[EB/OL]. [2021-05-25]. https://pharmaintelligence.informa.com/resources/product-content/car-t-payment-experiments-with-outcomes-based-contract., articleTitle=null, refAbstract=null), Reference(id=1330225036897661207, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=IHS Markit. Japan's new CEA-based price adjustments set to maintain pricing pressure on innovative drugs[EB/OL]. [2021-05-25]. https://ihsmarkit.com/research-analysis/japans-new-ceabased-price-adjustments.html., articleTitle=null, refAbstract=null), Reference(id=1330225036977352984, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=Finger Post. Focus on Japan: reimbursement decisions from January – May 2020[EB/OL]. [2021-05-25]. https://www.fingerpostconsulting.com/global-payer-insight-news/focus-on-japan-reimbursement-decisions-from-january-may-2020., articleTitle=null, refAbstract=null), Reference(id=1330225037048656153, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=Technology P. Japan's new CEA-based price adjustments set to maintain pricing pressure on innovative drugs[EB/OL]. [2021-12-25]. https://www.pharmaceutical-technology.com/pricing-and-market-access/japans-new-ceabased-price-adjustments-html/., articleTitle=null, refAbstract=null), Reference(id=1330225037119959322, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=张新庆. 基因治疗之伦理审视[M]. 北京: 中国社会科学出版社, 2014: 201-210., articleTitle=null, refAbstract=null)], funds=[Fund(id=1330225032388784365, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, awardId=19YBQ026, language=CN, fundingSource=湖南省哲学社会科学青年项目(19YBQ026), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1330225028932677820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, xref=1., ext=[AuthorCompanyExt(id=1330225028941066429, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225028932677820, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Public Health, Dalian Medical University, Dalian 116044, Liaoning Province, China), AuthorCompanyExt(id=1330225028949455038, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225028932677820, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.大连医科大学公共卫生学院,辽宁 大连 116044)]), AuthorCompany(id=1330225030513930431, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, xref=2., ext=[AuthorCompanyExt(id=1330225030522319040, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225030513930431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.China Welfare Association International Peace Maternal and Child Health Hospital, Shanghai 200030, China), AuthorCompanyExt(id=1330225030526513345, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225030513930431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国福利会国际和平妇幼保健院,上海 200030)]), AuthorCompany(id=1330225030593622210, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, xref=3., ext=[AuthorCompanyExt(id=1330225030602010819, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225030593622210, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Medical Insurance Administration, The First Hospital of Lanzhou University, Lanzhou 730013, Gansu Province, China), AuthorCompanyExt(id=1330225030610399428, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225030593622210, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.兰州大学第一医院医保管理处,甘肃 兰州 730013)]), AuthorCompany(id=1330225030694285509, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, xref=4., ext=[AuthorCompanyExt(id=1330225030702674118, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225030694285509, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.Shanghai Adverse Reaction Monitoring Center for Drugs and Medical Devices, Shanghai 200040, China), AuthorCompanyExt(id=1330225030706868423, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225030694285509, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.上海市药品和医疗器械不良反应监测中心,上海 200040)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.02.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.02.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2022.02.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2022.02.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1644422400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
基因治疗药物支付方式的国际经验及对我国的启示
袁妮 1 , 梁广盛 2 , 常翰玉 3 , 王美琪 1 , 关晓岩 1 , 胡骏 4
世界临床药物 | 医药专论 2022,43(2): 115-123
收起
收藏切换
世界临床药物 |医药专论 2022 , 43 (2) : 115 -123
基因治疗药物支付方式的国际经验及对我国的启示
全屏
[Author(id=1330225030773977289, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225030849474763, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225030773977289, language=EN, stringName=Ni YUAN, firstName=Ni, middleName=null, lastName=YUAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of Public Health, Dalian Medical University, Dalian 116044, Liaoning Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225030908195020, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225030773977289, language=CN, stringName=袁妮, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.大连医科大学公共卫生学院,辽宁 大连 116044, bio={"content":"

袁妮,副教授,研究方向:医疗保障政策、药物经济学、药物政策。

"}, bioImg=null, bioContent=

袁妮,副教授,研究方向:医疗保障政策、药物经济学、药物政策。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225028932677820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, xref=1., ext=[AuthorCompanyExt(id=1330225028941066429, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225028932677820, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Public Health, Dalian Medical University, Dalian 116044, Liaoning Province, China), AuthorCompanyExt(id=1330225028949455038, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225028932677820, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.大连医科大学公共卫生学院,辽宁 大连 116044)])]), Author(id=1330225030979498190, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225031046607056, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225030979498190, language=EN, stringName=Guangsheng LIANG, firstName=Guangsheng, middleName=null, lastName=LIANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.China Welfare Association International Peace Maternal and Child Health Hospital, Shanghai 200030, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225031122104529, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225030979498190, language=CN, stringName=梁广盛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.中国福利会国际和平妇幼保健院,上海 200030, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225030513930431, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, xref=2., ext=[AuthorCompanyExt(id=1330225030522319040, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225030513930431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.China Welfare Association International Peace Maternal and Child Health Hospital, Shanghai 200030, China), AuthorCompanyExt(id=1330225030526513345, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225030513930431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.中国福利会国际和平妇幼保健院,上海 200030)])]), Author(id=1330225031193407699, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225031273099477, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225031193407699, language=EN, stringName=Hanyu CHANG, firstName=Hanyu, middleName=null, lastName=CHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.Department of Medical Insurance Administration, The First Hospital of Lanzhou University, Lanzhou 730013, Gansu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225031336014038, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225031193407699, language=CN, stringName=常翰玉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=3, address=3.兰州大学第一医院医保管理处,甘肃 兰州 730013, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225030593622210, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, xref=3., ext=[AuthorCompanyExt(id=1330225030602010819, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225030593622210, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Medical Insurance Administration, The First Hospital of Lanzhou University, Lanzhou 730013, Gansu Province, China), AuthorCompanyExt(id=1330225030610399428, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225030593622210, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.兰州大学第一医院医保管理处,甘肃 兰州 730013)])]), Author(id=1330225031415705816, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225031491203290, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225031415705816, language=EN, stringName=Meiqi WANG, firstName=Meiqi, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of Public Health, Dalian Medical University, Dalian 116044, Liaoning Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225031545729243, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225031415705816, language=CN, stringName=王美琪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.大连医科大学公共卫生学院,辽宁 大连 116044, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225028932677820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, xref=1., ext=[AuthorCompanyExt(id=1330225028941066429, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225028932677820, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Public Health, Dalian Medical University, Dalian 116044, Liaoning Province, China), AuthorCompanyExt(id=1330225028949455038, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225028932677820, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.大连医科大学公共卫生学院,辽宁 大连 116044)])]), Author(id=1330225031608643806, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225031671558368, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225031608643806, language=EN, stringName=Xiaoyan GUAN, firstName=Xiaoyan, middleName=null, lastName=GUAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.School of Public Health, Dalian Medical University, Dalian 116044, Liaoning Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225031730278625, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225031608643806, language=CN, stringName=关晓岩, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.大连医科大学公共卫生学院,辽宁 大连 116044, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225028932677820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, xref=1., ext=[AuthorCompanyExt(id=1330225028941066429, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225028932677820, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Public Health, Dalian Medical University, Dalian 116044, Liaoning Province, China), AuthorCompanyExt(id=1330225028949455038, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225028932677820, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.大连医科大学公共卫生学院,辽宁 大连 116044)])]), Author(id=1330225031784804579, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225031856107749, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225031784804579, language=EN, stringName=Jun HU, firstName=Jun, middleName=null, lastName=HU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=4, address=4.Shanghai Adverse Reaction Monitoring Center for Drugs and Medical Devices, Shanghai 200040, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225031914828006, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, authorId=1330225031784804579, language=CN, stringName=胡骏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=4, address=4.上海市药品和医疗器械不良反应监测中心,上海 200040, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225030694285509, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, xref=4., ext=[AuthorCompanyExt(id=1330225030702674118, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225030694285509, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.Shanghai Adverse Reaction Monitoring Center for Drugs and Medical Devices, Shanghai 200040, China), AuthorCompanyExt(id=1330225030706868423, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225028316115127, companyId=1330225030694285509, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.上海市药品和医疗器械不良反应监测中心,上海 200040)])])]
袁妮1, 梁广盛2, 常翰玉3, 王美琪1, 关晓岩1, 胡骏4
作者信息
  • 1.大连医科大学公共卫生学院,辽宁 大连 116044
  • 2.中国福利会国际和平妇幼保健院,上海 200030
  • 3.兰州大学第一医院医保管理处,甘肃 兰州 730013
  • 4.上海市药品和医疗器械不良反应监测中心,上海 200040
作者简介:

袁妮,副教授,研究方向:医疗保障政策、药物经济学、药物政策。

International experience of gene therapy drug payment mode and its enlightenment to China
Ni YUAN1, Guangsheng LIANG2, Hanyu CHANG3, Meiqi WANG1, Xiaoyan GUAN1, Jun HU4
Affiliations
  • 1.School of Public Health, Dalian Medical University, Dalian 116044, Liaoning Province, China
  • 2.China Welfare Association International Peace Maternal and Child Health Hospital, Shanghai 200030, China
  • 3.Department of Medical Insurance Administration, The First Hospital of Lanzhou University, Lanzhou 730013, Gansu Province, China
  • 4.Shanghai Adverse Reaction Monitoring Center for Drugs and Medical Devices, Shanghai 200040, China
出版时间: 2022-02-10 doi: 10.13683/j.wph.2022.02.002
文章导航
收藏切换

基因治疗作为一种新型治疗手段,目前已被用于罕见病等多种疑难医学问题,为罕见病患者带来了新的希望。但目前基因治疗面临3大难题,包括生成/数据采集难、价值评估(包括定价和预算影响分析)难及支付报销难。因此,制定合理的付费模式对于保障患者生命健康权、提高基因治疗的患者可及性至关重要。该文以用于罕见病治疗的基因治疗药物为例,针对其支付报销难题,梳理了当前主流的几种付费模式和部分发达国家的具体实践,以探讨在不突破预算限制的条件下如何为昂贵的基因治疗药物买单。

罕见病  /  基因治疗药物  /  支付及报销

Gene therapy, as a new type of treatment, has been applied to rare disease and other difficult medical problems, bringing hopes to patients with rare disease. However, three major challenges including difficulty in evidence generating or data collection, value evaluation (including pricing and budget impact analysis) and difficulties in payment and reimbursement. Therefore, formulating a reasonable payment was essential to protect the health of patients and improve the accessibility of gene therapy. Taking gene therapy drugs for rare disease as an example, this article summarized the current payment models and some practices in developed countries, in order to discuss how to pay for expensive gene therapy drugs within the limited budget constraints.

rare disease  /  gene therapy  /  payment and reimbursement
袁妮, 梁广盛, 常翰玉, 王美琪, 关晓岩, 胡骏. 基因治疗药物支付方式的国际经验及对我国的启示. 世界临床药物, 2022 , 43 (2) : 115 -123 . DOI: 10.13683/j.wph.2022.02.002
Ni YUAN, Guangsheng LIANG, Hanyu CHANG, Meiqi WANG, Xiaoyan GUAN, Jun HU. International experience of gene therapy drug payment mode and its enlightenment to China[J]. World Clinical Drug, 2022 , 43 (2) : 115 -123 . DOI: 10.13683/j.wph.2022.02.002
  • 湖南省哲学社会科学青年项目(19YBQ026)
参考文献 引证文献
排序方式:
[1]
迟培娟, 陈芳, Liu C, 等. 基因治疗及细胞治疗发展态势分析[J]. 中国生物工程杂志, 2019, 39(5): 43-52.
[2]
张岩松, 陈丽娇, 张婷, 等. 基因治疗的研究进展[J]. 中国细胞生物学学报, 2020, 42(10): 1858-1869.
[3]
Wang D, Wang K, Cai Y. An overview of development in gene therapeutics in China[J]. Gene Ther, 2020, 27(7-8): 338-348.
[4]
HUML RA. Rare disease drug development, clinical, scientifc, patient, and caregiver perspectives[M]. Switzerland: Springer Nature Switzerland AG, 2021: 251-261.
[5]
Quinn C, Young C, Thomas J, et al. Estimating the clinical pipeline of cell and gene therapies and their potential economic impact on the US healthcare system[J]. Value Health, 2019, 22(6): 621-626.
[6]
桂怡婷, 李强, 桂永浩. 罕见病的基因治疗应用与展望[J]. 临床儿科杂志, 2020, 38(10): 794-798.
[7]
Toby Auwerter JS. Unlocking market access for gene therapies in the United States[EB/OL]. [2021-12-25]. https://www.mckinsey.com/industries/life-sciences/our-insights/unlocking-market-access-for-gene-therapies-in-the-united-states.
[8]
Ledley FD. 30 Years is too long to wait for new medicines. There are ways to speed up drug development[EB/OL]. [2021-12-25]. https://www.statnews.com/2018/06/06/drug-development-speed-new-medicines/.
[9]
Garrison LP, Jackson T, Paul D, et al. Value-based pricing for emerging gene therapies: the economic case for a higher cost-effectiveness threshold[J]. J Manag Care Spec Pharm, 2019, 25(7): 793-799.
[10]
Kent A, Spink J. Will rising prices and budget constraints prevent patients from accessing novel gene therapies?[J]. Gene Ther, 2017, 24(9): 542-543.
[11]
Agency EM. Glybera[EB/OL]. [2021-12-25]. https://www.ema.europa.eu/en/medicines/human/EPAR/glybera.
[12]
EMA, Wang ZL, Xu T, et al. The approved gene therapy drugs worldwide: from 1998 to 2019[J]. Biotechnol Adv, 2020, 40: 107502.
[13]
FDA. Approved cellular and gene therapy products[EB/OL]. [2021-12-25]. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/approved-cellular-and-gene-therapy-products.
[14]
Technology P. Bluebird turns heads with high pricing of gene therapy zynteglo in Europe[EB/OL]. [2021-12-30]. https://www.pharmaceutical-technology.com/comment/zynteglo-gene-therapy-2019/.
[15]
PMLIVE. NICE rejects Akcea's rare inherited disorder drug waylivra[EB/OL]. [2021-12-30]. https://www.pmlive.com/pharma_news/nice_rejects_akceas_rare_inherited_disorder_drug_waylivra_1321479.
[16]
Davio K. In developing payment mechanisms for gene therapies, the US has a long road ahead[EB/OL]. [2021-12-25]. https://www.ajmc.com/view/in-developing-payment-mechanisms-for-gene-therapies-the-us-has-a-long-road-ahead.
[17]
Dieg OB. Prices of new hepatitis C combinations lower than monotherapy in Spain in six months[EB/OL]. [2021-12-25]. https://www.apmhealtheurope.com/freestory/0/41690/prices-of-new-hepatitis-c-combinations-lower-than-monotherapy-in-spain-in-six-months.
[18]
Forbes. At over $2 million zolgensma is the world's most expensive therapy, yet relatively cost-effective[EB/OL]. [2021-12-25]. https://www.forbes.com/sites/joshuacohen/2019/06/05/at-over-2-million-zolgensma-is-the-worlds-most-expensive-therapy-yet-relatively-cost-effective/?sh=7bd7be7445f5.
[19]
Novartis. AveXis announces innovative zolgensma® gene therapy access programs for us payers and families[EB/OL]. [2021-12-25]. https://www.novartis.com/news/media-releases/avexis-announces-innovative-zolgensma-gene-therapy-access-programs-us-payers-and-families.
[20]
European Commission. European system of national and regional accounts - ESA 2010[EB/OL]. [2021-12-25]. https://ec.europa.eu/eurostat/web/esa-2010/overview.
[21]
Brennan TA, Wilson JM. The special case of gene therapy pricing[J]. Nat Biotechnol, 2014, 32(9): 874-876.
[22]
Jorgensen J, Kefalas P. Reimbursement of licensed cell and gene therapies across the major European healthcare markets[J]. J Mark Access Health Policy, 2015, 3(1): 29321.
[23]
Tapestry Network. Building a sustainable health system for curative therapies[EB/OL]. [2021-12-25]. https://www.tapestrynetworks.com/publications/building-a-sustainable-health-system-for-curative-therapies.
[24]
Grace Marsden ATSD. Gene therapy: understanding the science, assessing the evidence, and paying for value[R]. Institute for Clinical and Economic Review, 2017.
[25]
Bubela T, Mccabe C, Archibald P, et al. Bringing regenerative medicines to the clinic: the future for regulation and reimbursement[J]. Regen Med, 2015, 10(7): 897-911.
[26]
Hanna E, Marre C, Toumi M. Reimbursement of advanced therapy medicinal products in Europe[J]. Value Health, 2018, 21(suppl 3): S202-S203.
[27]
Carvalho M, Sepodes B, Martins AP. Patient access to gene therapy medicinal products: a comprehensive review[J]. BMJ Innovations, 2021, 7: 123-134.
[28]
Schwander B, Banz K, Kaier K, et al. Evaluation of a possible predictor for federal joint committee decisions on early benefit assessments according to the German act on the reform of the market for medicinal products[J]. Health Policy, 2014, 117(3): 334-344.
[29]
Ohlenbusch S. Novartis seeking more ‘innovative pay-ment models' for CAR-T Kymriah in Germany[EB/OL]. [2021-12-25]. https://www.apmhealtheurope.com/freestory/0/63585/novartis-seeking-more–innovative-payment-models–for-car-t-kymriah-in-Germany.
[30]
GKV-Spitzenverband. Erstattungsbetragsverhandlungen nach § 130b SGB V - Axicabtagen-Ciloleucel (Yescarta®). 2019 [2021-12-25]. https://www.gkv-spitzenverband.de/krankenversicherung/arzneimittel/verhandlungen_nach_amnog/ebv_130b/wirkstoff_945472.jsp.
[31]
Jørgensen J, Hanna E, Kefalas P. Outcomes-based reimbursement for gene therapies in practice: the experience of recently launched CAR-T cell therapies in major European countries[J]. J Market Access Health Policy, 2020, 8(1): 1715536.
[32]
ABMSC. European benchmark ATMP market entry from an HTA perspective[R]. Gothenburg: Monocl Strategy & Communication AB, 2020.
[33]
Pharma F. GSK inks money-back guarantee on $665K Strimvelis, blazing a trail for gene-therapy pricing[EB/OL]. [2021-12-25]. https://www.fiercepharma.com/pharma/gskinks-money-back-guarantee-665k-strimvelis-blazing-a-trail-for-gene-therapy-pricing.
[34]
Affairs H. Medicaid best price[EB/OL]. [2021-12-25]. https://www.healthaffairs.org/do/10.1377/hpb20171008.000173/full/.
[35]
Sachs R, Bagley N, Lakdawalla DN. Innovative contracting for pharmaceuticals and medicaid's best-price rule. J Health Polit Policy Law, 2018, 43(1): 5-18.
[36]
Health Affairs Blog. Proposed stark law, anti-kickback reforms aim to facilitate value-based care[EB/OL]. [2021-12-25]. https://www.healthaffairs.org/do/10.1377/hblog20191014.13154/full/.
[37]
Pharmafile. Novartis' Kymriah to be covered by Japan's national insurance system[EB/OL]. [2021-12-25]. http://www.pharmafile.com/news/522188/novartis-kymriah-be-covered-japans-national-insurance-system.
[38]
CJ Partners Inc. Regenerative medicine in Japan[EB/OL] [2021-12-25]. http://www.cj-partners.com/en/news/files/000026_en_01.pdf.
[39]
Van Overbeeke E, Michelsen S, Toumi M, et al. Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions[J]. Drug Discov Today, 2021, 26(2): 399-415.
[40]
Yu TTL, Gupta P, Ronfard V, et al. Recent progress in European advanced therapy medicinal products and beyond[J]. Front Bioeng Biotechnol, 2018, 6: 130.
[41]
Pharma Intelligence. Novartis begins CAR-T payment experiments with outcomes-based contract with CMS[EB/OL]. [2021-05-25]. https://pharmaintelligence.informa.com/resources/product-content/car-t-payment-experiments-with-outcomes-based-contract.
[42]
IHS Markit. Japan's new CEA-based price adjustments set to maintain pricing pressure on innovative drugs[EB/OL]. [2021-05-25]. https://ihsmarkit.com/research-analysis/japans-new-ceabased-price-adjustments.html.
[43]
Finger Post. Focus on Japan: reimbursement decisions from January – May 2020[EB/OL]. [2021-05-25]. https://www.fingerpostconsulting.com/global-payer-insight-news/focus-on-japan-reimbursement-decisions-from-january-may-2020.
[44]
Technology P. Japan's new CEA-based price adjustments set to maintain pricing pressure on innovative drugs[EB/OL]. [2021-12-25]. https://www.pharmaceutical-technology.com/pricing-and-market-access/japans-new-ceabased-price-adjustments-html/.
[45]
张新庆. 基因治疗之伦理审视[M]. 北京: 中国社会科学出版社, 2014: 201-210.
2022年第43卷第2期
14
4
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2022.02.002
  • 接收时间:2021-11-04
  • 首发时间:2026-11-19
  • 出版时间:2022-02-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2021-11-04
基金
湖南省哲学社会科学青年项目(19YBQ026)
作者信息
    1.大连医科大学公共卫生学院,辽宁 大连 116044
    2.中国福利会国际和平妇幼保健院,上海 200030
    3.兰州大学第一医院医保管理处,甘肃 兰州 730013
    4.上海市药品和医疗器械不良反应监测中心,上海 200040
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.02.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏